Crystalline form of inhibitor for sodium-glucose cotransporter 2

摘要

The present invention relates to an inhibitor for sodium-glucose cotransporter 2 and a crystal form of co-crystals of L-proline, a method for producing the same, a pharmaceutical composition containing the same, and uses thereof. Specifically, the sodium of the formula (1) inhibitors of the glucose cotransporter 2, that is, (2S, 3R, 4R, 5S, 6R) -2- (3- (4 - (((1R, 3s, 5S ) - bicyclo [3.1.0] hexan-3-yl) oxy) benzyl) -4-chloro-phenyl) -6- (hydroxymethyl) tetrahydro -2 H-pyran -3,4,5-triol and , Crystal forms of co-crystals with L-proline, a process for their preparation, pharmaceutical compositions comprising them, and uses thereof. (One)